 Sweta Patel
Concepts (95)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Hematopoietic Stem Cells | 5 | 2026 | 435 | 1.720 |
Why?
| | Myelodysplastic Syndromes | 2 | 2026 | 165 | 1.560 |
Why?
| | Leukemia, Myelogenous, Chronic, BCR-ABL Positive | 3 | 2025 | 127 | 1.510 |
Why?
| | Neoplastic Stem Cells | 5 | 2024 | 409 | 1.480 |
Why?
| | Transcriptome | 3 | 2022 | 1038 | 0.920 |
Why?
| | Niacinamide | 1 | 2026 | 104 | 0.910 |
Why?
| | Small Molecule Libraries | 1 | 2021 | 111 | 0.620 |
Why?
| | STAT3 Transcription Factor | 1 | 2021 | 206 | 0.600 |
Why?
| | Metabolome | 1 | 2021 | 388 | 0.520 |
Why?
| | Drug Resistance, Neoplasm | 2 | 2024 | 881 | 0.490 |
Why?
| | Leukemia, Myeloid, Acute | 4 | 2024 | 686 | 0.490 |
Why?
| | Signal Transduction | 2 | 2022 | 5216 | 0.290 |
Why?
| | Bone Marrow Cells | 2 | 2020 | 321 | 0.290 |
Why?
| | Single-Cell Analysis | 3 | 2026 | 362 | 0.250 |
Why?
| | Nicotinamide Phosphoribosyltransferase | 1 | 2026 | 26 | 0.250 |
Why?
| | Encephalomyelitis, Autoimmune, Experimental | 1 | 2026 | 69 | 0.230 |
Why?
| | Leukemia, Myeloid | 1 | 2025 | 48 | 0.220 |
Why?
| | Mice | 10 | 2026 | 18329 | 0.220 |
Why?
| | Cytotoxicity, Immunologic | 1 | 2025 | 224 | 0.210 |
Why?
| | Sequence Analysis, RNA | 1 | 2026 | 442 | 0.200 |
Why?
| | Glycolysis | 2 | 2024 | 340 | 0.190 |
Why?
| | Cholinergic Agents | 1 | 2022 | 18 | 0.180 |
Why?
| | Cell Lineage | 2 | 2021 | 377 | 0.170 |
Why?
| | Killer Cells, Natural | 1 | 2025 | 480 | 0.170 |
Why?
| | Cytokines | 2 | 2026 | 2067 | 0.170 |
Why?
| | Isocitrate Dehydrogenase | 1 | 2021 | 72 | 0.170 |
Why?
| | GATA2 Transcription Factor | 1 | 2021 | 14 | 0.170 |
Why?
| | Lymphopoiesis | 1 | 2020 | 27 | 0.160 |
Why?
| | Thymocytes | 1 | 2020 | 33 | 0.160 |
Why?
| | Stromal Cells | 1 | 2020 | 121 | 0.160 |
Why?
| | Neutrophils | 1 | 2026 | 1124 | 0.160 |
Why?
| | Chemical Fractionation | 1 | 2019 | 29 | 0.150 |
Why?
| | Animals | 10 | 2026 | 38030 | 0.150 |
Why?
| | Transforming Growth Factor beta | 1 | 2022 | 474 | 0.150 |
Why?
| | Epigenesis, Genetic | 1 | 2024 | 679 | 0.150 |
Why?
| | Interleukin-1beta | 1 | 2021 | 389 | 0.150 |
Why?
| | Receptors, Prolactin | 1 | 2019 | 6 | 0.150 |
Why?
| | Hematopoiesis | 1 | 2020 | 193 | 0.150 |
Why?
| | Cadherins | 1 | 2021 | 200 | 0.150 |
Why?
| | Receptor, IGF Type 1 | 1 | 2019 | 64 | 0.150 |
Why?
| | Human Growth Hormone | 1 | 2019 | 47 | 0.140 |
Why?
| | Interleukin-10 | 1 | 2020 | 309 | 0.140 |
Why?
| | Cell Differentiation | 3 | 2021 | 2046 | 0.140 |
Why?
| | Calcium | 1 | 2024 | 1190 | 0.140 |
Why?
| | Mitochondria | 1 | 2024 | 992 | 0.130 |
Why?
| | T-Lymphocytes, Regulatory | 1 | 2020 | 409 | 0.130 |
Why?
| | Macrophages | 1 | 2024 | 1507 | 0.120 |
Why?
| | B-Lymphocytes | 1 | 2022 | 870 | 0.120 |
Why?
| | Carrier Proteins | 1 | 2019 | 728 | 0.110 |
Why?
| | Protein Kinase Inhibitors | 1 | 2021 | 981 | 0.110 |
Why?
| | Inflammation | 1 | 2025 | 2878 | 0.100 |
Why?
| | RNA | 1 | 2019 | 910 | 0.100 |
Why?
| | Apoptosis | 1 | 2021 | 2440 | 0.090 |
Why?
| | T-Lymphocytes | 1 | 2020 | 1996 | 0.090 |
Why?
| | Prostatic Neoplasms | 1 | 2019 | 978 | 0.090 |
Why?
| | Bridged Bicyclo Compounds, Heterocyclic | 2 | 2024 | 280 | 0.090 |
Why?
| | Sulfonamides | 2 | 2024 | 583 | 0.080 |
Why?
| | Humans | 9 | 2026 | 145474 | 0.080 |
Why?
| | Mice, Inbred C57BL | 3 | 2026 | 5983 | 0.070 |
Why?
| | Suppressor of Cytokine Signaling 3 Protein | 1 | 2026 | 11 | 0.060 |
Why?
| | Breast Neoplasms | 1 | 2019 | 2382 | 0.060 |
Why?
| | Fusion Proteins, bcr-abl | 1 | 2025 | 68 | 0.050 |
Why?
| | Cell Line, Tumor | 2 | 2024 | 3542 | 0.050 |
Why?
| | Disease Models, Animal | 2 | 2025 | 4560 | 0.050 |
Why?
| | Antigens, CD34 | 1 | 2023 | 89 | 0.050 |
Why?
| | Oxidative Phosphorylation | 1 | 2024 | 209 | 0.050 |
Why?
| | Cells, Cultured | 2 | 2021 | 4148 | 0.050 |
Why?
| | Lupus Erythematosus, Systemic | 1 | 2024 | 238 | 0.040 |
Why?
| | Female | 4 | 2026 | 78844 | 0.040 |
Why?
| | Basophils | 1 | 2021 | 52 | 0.040 |
Why?
| | Tumor Microenvironment | 1 | 2025 | 734 | 0.040 |
Why?
| | Primary Cell Culture | 1 | 2021 | 172 | 0.040 |
Why?
| | Coculture Techniques | 1 | 2020 | 247 | 0.040 |
Why?
| | Spectrum Analysis | 1 | 2019 | 85 | 0.040 |
Why?
| | Mast Cells | 1 | 2021 | 147 | 0.040 |
Why?
| | STAT5 Transcription Factor | 1 | 2019 | 50 | 0.040 |
Why?
| | Male | 3 | 2021 | 72842 | 0.040 |
Why?
| | Immunophenotyping | 1 | 2020 | 319 | 0.040 |
Why?
| | Chronic Disease | 1 | 2025 | 1808 | 0.040 |
Why?
| | Cell Communication | 1 | 2020 | 328 | 0.040 |
Why?
| | Autoimmunity | 1 | 2024 | 933 | 0.030 |
Why?
| | Protein Domains | 1 | 2019 | 311 | 0.030 |
Why?
| | High-Throughput Nucleotide Sequencing | 1 | 2020 | 530 | 0.030 |
Why?
| | Cattle | 1 | 2019 | 946 | 0.030 |
Why?
| | Polymerase Chain Reaction | 1 | 2019 | 1041 | 0.030 |
Why?
| | Binding Sites | 1 | 2019 | 1310 | 0.030 |
Why?
| | Disease Progression | 1 | 2023 | 2864 | 0.030 |
Why?
| | Computational Biology | 1 | 2020 | 669 | 0.030 |
Why?
| | Gene Expression Regulation, Developmental | 1 | 2020 | 910 | 0.030 |
Why?
| | Gene Expression Profiling | 1 | 2020 | 1767 | 0.020 |
Why?
| | DNA | 1 | 2019 | 1435 | 0.020 |
Why?
| | Cell Proliferation | 1 | 2020 | 2507 | 0.020 |
Why?
| | Antineoplastic Agents | 1 | 2024 | 2214 | 0.020 |
Why?
| | Mutation | 1 | 2021 | 4075 | 0.020 |
Why?
| | Biomarkers | 1 | 2020 | 4295 | 0.020 |
Why?
|
|
Patel's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|